Evidence map›Paper›PMID 38719510›Full record

ArticleBMJ open diabetes research & care2024

Multidisciplinary proactive e-consults to improve guideline-directed medical therapies for patients with diabetes and chronic kidney disease: an implementation study.

Sharon Rikin, Laurie Bauman, Ivelina Arnaoudova, Katherine DiPalo, Nisha Suda, Sonali Gupta, Yuting Deng, Ladan Golestaneh

Abstract read
In one paragraph

Article in BMJ open diabetes research & care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Care of Adults with Advanced Chronic Kidney Disease.Journal of clinical medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sharon RikinAlbert Einstein College of Medicine, Bronx, New York, USA srikin@montefiore.org.ORCID 0000-0002-2280-9033
Laurie BaumanAlbert Einstein College of Medicine, Bronx, New York, USA.
Ivelina ArnaoudovaAlbert Einstein College of Medicine, Bronx, New York, USA.
Katherine DiPaloAlbert Einstein College of Medicine, Bronx, New York, USA.
Nisha SudaAlbert Einstein College of Medicine, Bronx, New York, USA.
Sonali GuptaAlbert Einstein College of Medicine, Bronx, New York, USA.
Yuting DengAlbert Einstein College of Medicine, Bronx, New York, USA.
Ladan GolestanehAlbert Einstein College of Medicine, Bronx, New York, USA.

Funding

Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY E. PESSIN · 2015 to 2026
$27.7M
New York Regional Center for Diabetes Translation Research - Translational Intervention Methodology CoreP30DK111022 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY GONZALEZ · 2016 to 2026
$7.8M
Multidisciplinary electronic consultation to improve evidence-based care for patients with diabetic kidney diseaseR03HS028877 · AHRQ · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI GOLESTANEH, LADAN, RIKIN, SHARON · 2022 to 2022
$100k
AHRQ HHS R03 HS028877NIDDK NIH HHS P30 DK020541NIDDK NIH HHS P30 DK111022
6 · The paper itself

Abstract

introductionWe hypothesized that multidisciplinary, proactive electronic consultation (MPE) could overcome barriers to prescribing guideline-directed medical therapies (GDMTs) for patients with type 2 diabetes (T2D) and chronic kidney disease (CKD). RESEARCH DESIGN AND

methodsWe conducted an efficacy-implementation pilot study of MPE for T2D and CKD for primary care provider (PCP)-patient dyads at an academic health system. MPE included (1) a dashboard to identify patients without a prescription for sodium-glucose cotransporter-2 inhibitors (SGLT2i) and without a maximum dose prescription for renin-angiotensin-aldosterone system inhibitors (RAASi), (2) a multidisciplinary team of specialists to provide recommendations using e-consult templates, and (3) a workflow to deliver timely e-consult recommendations to PCPs. In-depth interviews were conducted with PCPs and specialists to assess feasibility, acceptability, and appropriateness of MPE and were analyzed using an iterative qualitative analysis approach to identify major themes. Prescription data were extracted from the electronic health record to assess preliminary effectiveness to increase GDMT.

results20 PCPs agreed to participate, 18 PCPs received MPEs for one of their patients with T2D and CKD, and 16 PCPs and 2 specialists were interviewed. Major themes were as follows: appropriateness of prioritization of GDMT for T2D and CKD, acceptability of the content of the recommendations, PCP characteristics impact experience with MPE, acceptability and appropriateness of multidisciplinary collaboration, feasibility of MPE to overcome patient-specific barriers to GDMT, and appropriateness of workflow. At 6 months postbaseline, 7/18 (39%) patients were newly prescribed an SGLT2i, and 7/18 (39%) patients were either newly prescribed or had increased dose of RAASi.

conclusionsMPE was an acceptable and appropriate health system strategy to identify and address gaps in GDMT among patients with T2D and CKD. Adopting MPE could enhance GDMT, though PCPs raised feasibility concerns which could be improved with program enhancements, including follow-up e-consults for reinforcement, and administrative support for navigating system-level barriers.

Indexed as

Diabetes Mellitus, Type 2Referral and ConsultationRenal Insufficiency, ChronicAgedFemaleFollow-Up StudiesGuideline AdherenceHumansMaleMiddle AgedPatient Care TeamPilot ProjectsPractice Guidelines as TopicPractice Patterns, Physicians'Primary Health CarePrognosisSodium-Glucose Transporter 2 InhibitorsDiabetes Mellitus, Type 2Health Services ResearchKidney DiseasesQuality Improvement

Identifiers

PMID38719510
PMCPMC11085711

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.